ZDF
Sign inSign up

Vulnerabilities

Security fix · CVE-2025-68457

Orejime is a consent manager that focuses on accessibility.

Published Dec 19, 2025 · catalog updated Jan 13, 2026 · Orejime is a consent

Last checked Nov 3, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2025-68457. EPSS is 0.22%. Act only if a listed version of Orejime is a consent is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (Orejime is a consent).
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.

Same product and reporting

Severity
Low0.6
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.22%
Remediation
Version ranges on file
Affected products
vendor boscop-fr orejime < 2.3.2

Orejime is a consent manager that focuses on accessibility. On HTML elements handled by Orejime prior to version 2.3.2, one could run malicious code by embedding code within data attributes. When consenting to the related purpose, Orejime would turn data attributes into unprefixed ones (i.e. into ), thus executing the code. This shouldn't have any impact on most setups, as elements handled by Orejime are generally hardcoded. The problem would only arise if somebody could inject HTML code within pages. The problem has been patched in version 2.3.2. As a workaround, the problem can be fixed outs

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor boscop-fr orejime < 2.3.2< 2.3.2

How to fix CVE-2025-68457

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-68457. EPSS is 0.22%. Act only if a listed version of Orejime is a consent is installed.

Which versions are affected?

Compare what you have installed with boscop-fr orejime < 2.3.2 < 2.3.2. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.22%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Dec 19, 2025 · EUVD

    Detected

    Orejime is a consent manager that focuses on accessibility. On HTML elements handled by Orejime prior to version 2.3.2, one could run malicious code by embedding code within data attributes. When consenting to the related purpose, Orejime would turn data attributes into unprefixed ones (i.e. into ), thus executing the code. This shouldn't have any impact on most setups, as elements handled by Orej

  2. Jan 13, 2026 · EUVD

    Updated

    Orejime is a consent manager that focuses on accessibility. On HTML elements handled by Orejime prior to version 2.3.2, one could run malicious code by embedding code within data attributes. When consenting to the related purpose, Orejime would turn data attributes into unprefixed ones (i.e. into ), thus executing the code. This shouldn't have any impact on most setups, as elements handled by Orej

Sources

  • CVE.orgVulnerability recordCVE-2025-68457

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-68457

    30-day exploitation probability 0.22%

    first.org
  • EUVDVulnerability recordEUVD-2025-204585

    Orejime is a consent manager that focuses on accessibility. On HTML elements handled by Orejime prior to version 2.3.2, one could run malicious code by embedding code within data attributes. When consenting to the related purpose, Orejime would turn data attributes into unprefixe

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Nov 3, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • FIRST EPSSNov 3, 2026
  • CVE.orgOct 30, 2026
  • EUVDOct 30, 2026